52-Week Performance Chart

Powered by FactSet Research Systems Inc

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Mar 05, 2018 3.41 20,616,438
0
20,616,438
70,302,054
0
70,302,054
Aug 11, 2016 2.85 24,265,000
0
24,265,000
69,155,250
0
69,155,250
Mar 30, 2015 .15 352,150,790
0
352,150,790
52,822,618
0
52,822,618
Jul 12, 2013 5.60 21,700,000
0
21,700,000
121,520,000
0
121,520,000

No DR Special Notices are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Sarissa Capital Management LP 1,242,531
Kynam Capital Management LP 620,731
Acadian Asset Management LLC 189,576
TOP MUTUAL FUND HOLDERS POSITION
PSM Macro Strategy 41,500
PSM Value Strategy UI 20,505
Old Westbury Small & Mid Cap Strategies Fund 18,397

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol AMRN
CUSIP 023111404
DR Venue NASDAQ Stock Market
DR ISIN US0231114044
Ratio DR:ORD 1:20
Underlying ISIN GB00B29VL935
Country United Kingdom
Effective Date Apr 08, 1993
Depositary CIT (Sponsored)
Industry Pharma. & Biotech.
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 -1.00 15,871,662 1,983,958
Mar.25 0.45 44,088,132 2,099,435
Feb.25 0.54 17,290,021 910,001

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE